Stemtech annual gross margin
2021
2022
2023
2024
2025
Stemtech's gross margin was 80.29% for fiscal 2025.
View full Stemtech company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 80.29% | +6.53 pp |
| 2024 | 2024-12-31 | 73.75% | −5.89 pp |
| 2023 | 2023-12-31 | 79.65% | +5.18 pp |
| 2022 | 2022-12-31 | 74.47% | −1.85 pp |
| 2021 | 2021-12-31 | 76.32% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 74.00% | −5.10 pp |
| Q1 2026 | 2026-03-31 | 76.39% | −6.59 pp |
| Q4 2025 | 2025-12-31 | 77.42% | −2.13 pp |
| Q3 2025 | 2025-09-30 | 80.08% | +16.93 pp |
| Q2 2025 | 2025-06-30 | 79.09% | +4.15 pp |
| Q1 2025 | 2025-03-31 | 82.98% | +7.96 pp |
| Q4 2024 | 2024-12-31 | 79.55% | −4.31 pp |
| Q3 2024 | 2024-09-30 | 63.15% | −14.45 pp |
| Q2 2024 | 2024-06-30 | 74.95% | −3.23 pp |
| Q1 2024 | 2024-03-31 | 75.02% | −3.38 pp |
| Q4 2023 | 2023-12-31 | 83.86% | +14.21 pp |
| Q3 2023 | 2023-09-30 | 77.59% | −5.16 pp |
| Q2 2023 | 2023-06-30 | 78.18% | +8.98 pp |
| Q1 2023 | 2023-03-31 | 78.40% | +1.11 pp |
| Q4 2022 | 2022-12-31 | 69.66% | −16.42 pp |
| Q3 2022 | 2022-09-30 | 82.75% | +9.01 pp |
| Q2 2022 | 2022-06-30 | 69.19% | −14.06 pp |
| Q1 2022 | 2022-03-31 | 77.29% | −5.38 pp |
| Q3 2021 · Sep 30 | 2021-09-30 | 86.07% | — |
| Q3 2021 · Jun 30 | 2021-06-30 | 73.74% | — |
| Q2 2021 · Mar 31 | 2021-03-31 | 83.25% | — |
| Q3 2021 · Sep 30 | 2020-09-30 | 82.67% | — |
Across the available reported history, Stemtech's gross margin increased from 73.75% to 80.29%, a change of +6.53 percentage points. The latest reported quarter, Q2 2026, shows 74.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stemtech filings at SEC.gov ↗